
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1042 | 1020 | 1092 | 1191 | 1281 | 1508 |
Fund Return | 4.22% | 2% | 9.16% | 6% | 5.07% | 4.19% |
Place in category | 573 | 570 | 580 | 433 | 424 | 315 |
% in Category | 86 | 88 | 93 | 81 | 91 | 89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UK Equity Income Fund Institutional | 86.96M | 3.09 | 8.21 | 6.55 | ||
UK Equity Income Fund Retail Income | 132.72M | 3.04 | 7.62 | 5.96 | ||
UK Equity Income Fund Retail Accumu | 112.46M | 1.63 | 8.03 | 5.61 | ||
UK Equity Income Fund Z Accumulatio | 596.05M | 3.11 | 8.46 | 6.78 | ||
UK Equity Income Fund Z Income GBP | 600.01M | 3.11 | 8.47 | 6.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.83B | 6.89 | 8.27 | 6.15 | ||
All Share Index Unit Trust Income | 14.83B | 9.33 | 5.75 | 6.09 | ||
VG UK Plus GBP Accumulation | 14.83B | 9.34 | 5.76 | 6.12 | ||
VG UK Institutional Plus GBP Income | 14.83B | 9.34 | 5.75 | 6.11 | ||
UK Equity Tracker Fund D Acc | 12.42B | 6.05 | 8.74 | 6.23 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 7.23 | 11,196.0 | -1.93% | |
Shell | GB00BP6MXD84 | 6.55 | 33.69 | +0.33% | |
Unilever | GB00B10RZP78 | 5.13 | 55.36 | +0.91% | |
London Stock Exchange | GB00B0SWJX34 | 4.01 | 11,405.0 | -1.08% | |
Relx | GB00B2B0DG97 | 3.60 | 3,879.00 | -0.21% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Neutral | Strong Sell | Strong Buy |
Summary | Neutral | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review